Fineimmu
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A research-stage biotech engineering novel antibody therapies for immune-related diseases and cancer.
OncologyImmunology
Technology Platform
An antibody engineering platform focused on creating novel formats and optimizing functions for immune modulation.
Opportunities
Potential to discover a breakthrough antibody against a novel target, creating significant partnering value.
Risk Factors
Risk of its lead candidate failing in IND-enabling studies or being overshadowed by competitors' advancements.
Competitive Landscape
Operates in a vast and competitive preclinical arena where scientific differentiation is critical for survival.